NYSE - Nasdaq Real Time Price USD

West Pharmaceutical Services, Inc. (WST)

334.29 -2.72 (-0.81%)
At close: May 22 at 4:00 PM EDT
330.11 -4.18 (-1.25%)
After hours: May 22 at 6:58 PM EDT
Loading Chart for WST
DELL
  • Previous Close 337.01
  • Open 336.56
  • Bid 285.00 x 1000
  • Ask 334.40 x 1100
  • Day's Range 329.31 - 340.42
  • 52 Week Range 310.42 - 415.73
  • Volume 659,498
  • Avg. Volume 485,945
  • Market Cap (intraday) 24.671B
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) 44.45
  • EPS (TTM) 7.52
  • Earnings Date Jul 25, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 0.80 (0.24%)
  • Ex-Dividend Date Jul 31, 2024
  • 1y Target Est 405.86

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

www.westpharma.com

10,600

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WST

Performance Overview: WST

Trailing total returns as of 5/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WST
4.96%
S&P 500
11.26%

1-Year Return

WST
4.66%
S&P 500
26.60%

3-Year Return

WST
0.93%
S&P 500
27.70%

5-Year Return

WST
185.81%
S&P 500
85.28%

Compare To: WST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WST

Valuation Measures

Annual
As of 5/22/2024
  • Market Cap

    24.35B

  • Enterprise Value

    24.06B

  • Trailing P/E

    44.10

  • Forward P/E

    44.64

  • PEG Ratio (5yr expected)

    6.03

  • Price/Sales (ttm)

    8.56

  • Price/Book (mrq)

    9.08

  • Enterprise Value/Revenue

    8.21

  • Enterprise Value/EBITDA

    29.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.42%

  • Return on Assets (ttm)

    11.40%

  • Return on Equity (ttm)

    20.84%

  • Revenue (ttm)

    2.93B

  • Net Income Avi to Common (ttm)

    568.7M

  • Diluted EPS (ttm)

    7.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    601.8M

  • Total Debt/Equity (mrq)

    11.44%

  • Levered Free Cash Flow (ttm)

    143.34M

Research Analysis: WST

Company Insights: WST

Research Reports: WST

People Also Watch